from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2MbNdrO on January 14, 2019 at 04:51PM
Join industry experts Julie Carter, Category Director of RWE & HEOR, Scientist.com, Patti Peeples, RPh, PhD, CEO and Founder of HealthEconomics.com and Principal Researcher at HE Institute and Mary Beth Ritchey, PhD, Director of Epidemiology for Medical Devices at RTI Health Solutions for a live webinar on Thursday, January 24, 2019 at 12pm EST (5pm GMT).
It is becoming apparent to many organizations that one of the best solutions is to leverage experienced service providers, who are often also knowledgeable about the Health Technology Assessment (HTA) and regulatory requirements across various regions. These challenges make outsourcing expert service providers inevitable and a key to driving the value story of products.
However, outsourcing can lead to long contracting times and difficulties in locating the right supplier, especially as the demand for RWE as part of an HEOR strategy increases.
All of this leads one to ask: how does outsourcing support RWE for generating value evidence when the practice of outsourcing itself presents its own challenges?
Some questions that will be answered include:
What is RWE and HEOR?
- What are some of the major challenges when sourcing HEOR and RWE?
- What sourcing trends are occurring in the global strategy and regulation of RWE (including HEOR, epidemiology, market access and other RWE)?
- What are the best practices and strategies when sourcing HEOR and RWE services?